Ranch Capital Advisors’s ANI Pharmaceuticals ANIP Stock Holding History

Ranch Capital Advisors’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-56	Closed	-$3K	–	870
2019 Q4	$3K	Buy	+56	New	+$3.71K	﹤0.01%	838

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Mangrove Partners Greenwich, Connecticut $1.52B AUM 36.54% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ICOM

Investment Counselors of Maryland Baltimore, Maryland $4.37B AUM 76.25% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

First Manhattan New York $39.2B AUM 21.04% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Ranch Capital Advisors's ANIP Position: Q1 2020 in Review

Ranch Capital Advisors sold out of ANI Pharmaceuticals (ANIP) in Q1 2020, closing a stake of 56 shares — an estimated $3K sold.

Ranch Capital Advisors first reported a position in ANIP in Q4 2019 and held it in 1 quarter. The position peaked at $3K in Q4 2019. 140 funds tracked by Wall St. Rank hold ANIP as of Q1 2020.

Ranch Capital Advisors reported no remaining ANI Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
Ranch Capital Advisors sold 56 ANI Pharmaceuticals shares in Q1 2020, an estimated $3K.
Ranch Capital Advisors first reported a position in ANI Pharmaceuticals in Q4 2019 and held it in 1 quarter.
Ranch Capital Advisors's ANI Pharmaceuticals position peaked at $3K in Q4 2019.
140 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2020.

Based on Ranch Capital Advisors's 13F filing for Q1 2020, filed 12 May 2020.